文献速递骨肌技术与安全MR

使用扩散MRI对骨肉瘤进行自动分割与RECIST评分评估:一种计算机辅助系统流程

Automatic segmentation and RECIST score evaluation in osteosarcoma using diffusion MRI: A computer aided system process.
PubMed 文献 · Eur J Radiol · 2020-10-20

本研究纳入40例骨肉瘤患者,在1.5T MRI上采集新辅助化疗前后DWI,采用SLIC-S与FCM两种自动分割方法,与人工勾画的金标准比较ADC、肿瘤直径、最大负荷层面编号和肿瘤体积,并评估RECIST1.1与容积反应评分的误分类率。两种方法分割与测量结果与金标准相关性好,误分类率分别为RECIST1.1 15–18%、容积反应18–20%,单例评估耗时2–3秒和4–6秒。

要点

  • SLIC-S与FCM自动分割DWI骨肉瘤的Dice系数约70–83%,与金标准测量ADC、直径、体积相关性好。
  • 自动RECIST1.1评分误分类率15–18%,容积反应评分误分类率18–20%,单例评估约2–6秒。
  • 作者认为该方法在当前骨肿瘤数据集上表现有前景,可能作为其他肿瘤疗效评估的决策支持工具。

关键影像表现/征象

  • 在分割出的肿瘤掩膜与金标准肿瘤掩膜之间比较ADC、肿瘤直径、最大负荷层面编号和肿瘤体积,配对t检验p>0.05。
  • SLIC-S与FCM在基线与随访时估算ADC的PCC=0.84–0.89,肿瘤直径PCC=0.90–0.95、偏倚0.3–2.41,最大负荷层面编号PCC=0.87–0.96,肿瘤体积PCC=0.89–0.94、偏倚15.19–131.81。
  • 肿瘤体积变化百分比跨时间点按RECIST1.1与容积反应标准评分。

诊断标准与关键数值

  • 分割精度:Dice系数约70–83%,Jaccard指数约55–72%,精确率约64–85%,召回率约73–83%。
  • 自动RECIST1.1评分误分类率:SLIC-S与FCM分别为15–18%;容积反应评分误分类率:SLIC-S与FCM分别为18–20%。
  • 单例评估时间:SLIC-S为2–3秒,FCM为4–6秒。

临床应用与阅片要点

  • 作者认为该方法可能作为决策支持工具用于其他肿瘤的疗效评估。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

PURPOSE: Accuracy and consistency in RECIST (Response evaluation criteria in solid tumors) measurements are crucial for treatment planning. Manual RECIST measurement is tedious, prone-to-error and operator-subjective. Objective was to develop a fully automated system for tumor segmentation and RECIST score estimation with reasonable accuracy, consistency and speed.

METHODS: Diffusion weight images (DWI) of forty patients (N = 40; Male:Female = 30:10; Age = 17.7 ± 5.9years) with Osteosarcoma was acquired using 1.5 T MRI scanner before (baseline) and after neoadjuvant chemotherapy (follow-up). 3D tumor volume was segmented applying Simple-linear-iterative-clustering Superpixels (SLIC-S) and Fuzzy-c-means-clustering (FCM) separately. Connected-component-analysis was performed to identify image-slice with maximum tumor-burden (Max-burden-sliceno) and measure tumor-sizes (Tumor-diameter(cm) & Tumor-volume(cc)). Relative-percentage-changes in tumor-sizes across time-points were scored using RECIST1.1 and Volumetric-response criterion. Segmentation accuracy was estimated by Dice-coefficient (DC), Jaccard-Index (JI), Precision (P) and Recall (R). Evaluated Apparent-diffusion-coefficient (ADC), Tumor-diameter, Max-burden-sliceno and Tumor-volume in segmented tumor-mask and ground-truth tumor-mask were compared using paired-t-test (p < 0.05), Pearson-correlation-coefficient(PCC) and Bland-Altman plots. Misclassification-error-rate (MER) was evaluated for automated RECIST1.1 and Volumetric-response scoring methods.

RESULTS: Automated SLIC-S and FCM produced satisfactory tumor segmentation (DC:∼70-83%;JI:∼55-72%;P:∼64-85%;R:∼73-83%) and showed excellent correlation with ground-truth measurements in estimating ADC (p > 0.05; PCC=0.84-0.89), Tumor-diameters (p > 0.05; PCC=0.90-0.95; bias=0.3-2.41), Max-burden-sliceno (p > 0.05; PCC=0.87-0.96) and Tumor-volumes (p > 0.05; PCC=0.89-0.94; bias=15.19-131.81) at baseline and follow-up. MER for SLIC-S and FCM were comparable for RECIST1.1 (15-18 %) and Volumetric-response (18-20 %) scores and assessment times were 2-3s and 4-6s per patient respectively.

CONCLUSIONS: Proposed method produced promising segmentation and RECIST score measurements in current bone tumor dataset and might be useful as decision-support-tool for response evaluation in other tumors.

来源:Eur J Radiol,查看原文。版权归原作者所有。

引用

  1. Baidya Kayal E, Kandasamy D, Yadav R, et al. Automatic segmentation and RECIST score evaluation in osteosarcoma using diffusion MRI: A computer aided system process. Eur J Radiol. 2020. PMID: 33129104. doi:10.1016/j.ejrad.2020.109359

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。